End-of-day quote
Shanghai S.E.
06:00:00 2024-05-09 pm EDT
|
5-day change
|
1st Jan Change
|
19.97
CNY
|
-3.01%
|
|
+0.66%
|
-31.77%
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
14,529
|
7,526
|
5,800
|
3,953
|
-
|
-
|
Enterprise Value (EV)
1 |
14,529
|
7,526
|
5,800
|
3,953
|
3,953
|
3,953
|
P/E ratio
|
112
x
|
47.7
x
|
244
x
|
29.2
x
|
19.6
x
|
16
x
|
Yield
|
0.25%
|
0.53%
|
0.34%
|
1%
|
-
|
-
|
Capitalization / Revenue
|
34.4
x
|
12.5
x
|
12.5
x
|
4.56
x
|
3.36
x
|
3.41
x
|
EV / Revenue
|
34.4
x
|
12.5
x
|
12.5
x
|
4.56
x
|
3.36
x
|
3.41
x
|
EV / EBITDA
|
95.7
x
|
36.2
x
|
59.7
x
|
23.3
x
|
16
x
|
11.7
x
|
EV / FCF
|
-
|
-21,271,958
x
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-0%
|
-
|
-
|
-
|
-
|
Price to Book
|
11.9
x
|
3.33
x
|
2.61
x
|
1.71
x
|
1.56
x
|
1.49
x
|
Nbr of stocks (in thousands)
|
182,164
|
199,775
|
198,171
|
197,965
|
-
|
-
|
Reference price
2 |
79.76
|
37.67
|
29.27
|
19.97
|
19.97
|
19.97
|
Announcement Date
|
2/23/22
|
2/27/23
|
2/23/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
422.7
|
603
|
464.5
|
867.4
|
1,178
|
1,158
|
EBITDA
1 |
-
|
151.9
|
207.6
|
97.21
|
169.7
|
247.2
|
336.6
|
EBIT
1 |
-
|
122.6
|
163.4
|
18.07
|
78.77
|
205.2
|
180.3
|
Operating Margin
|
-
|
29.01%
|
27.1%
|
3.89%
|
9.08%
|
17.42%
|
15.57%
|
Earnings before Tax (EBT)
1 |
-
|
123.8
|
167.7
|
17.77
|
80.48
|
209.1
|
181.4
|
Net income
1 |
45.09
|
108.2
|
146.9
|
24.52
|
136.5
|
204.2
|
250.4
|
Net margin
|
-
|
25.6%
|
24.36%
|
5.28%
|
15.74%
|
17.34%
|
21.62%
|
EPS
2 |
0.3300
|
0.7100
|
0.7900
|
0.1200
|
0.6850
|
1.020
|
1.250
|
Free Cash Flow
|
-
|
-
|
-353.8
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-58.67%
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
0.2000
|
0.2000
|
0.1000
|
0.2000
|
-
|
-
|
Announcement Date
|
7/28/21
|
2/23/22
|
2/27/23
|
2/23/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-354
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
14.4%
|
9.71%
|
1.09%
|
5.67%
|
7.81%
|
9.36%
|
ROA (Net income/ Total Assets)
|
-
|
10.7%
|
6.66%
|
0.82%
|
3.45%
|
4.1%
|
-
|
Assets
1 |
-
|
1,007
|
2,206
|
2,980
|
3,957
|
4,981
|
-
|
Book Value Per Share
2 |
-
|
6.730
|
11.30
|
11.20
|
11.70
|
12.80
|
13.40
|
Cash Flow per Share
2 |
-
|
-0.2200
|
0.2500
|
0.0300
|
0.1500
|
1.800
|
1.180
|
Capex
1 |
-
|
159
|
404
|
414
|
358
|
330
|
249
|
Capex / Sales
|
-
|
37.72%
|
67.04%
|
89.12%
|
41.3%
|
28.05%
|
21.49%
|
Announcement Date
|
7/28/21
|
2/23/22
|
2/27/23
|
2/23/24
|
-
|
-
|
-
|
Last Close Price
19.97
CNY Average target price
26.47
CNY Spread / Average Target +32.53% Consensus |
1st Jan change
|
Capi.
|
---|
| -31.77% | 547M | | +5.97% | 105B | | -4.19% | 63.99B | | +51.90% | 42.95B | | +17.44% | 39.2B | | +6.62% | 33.01B | | +13.00% | 20.33B | | +15.64% | 17.29B | | +22.55% | 15.72B | | +7.34% | 14.72B |
Other Commodity Chemicals
|